Header Logo

Connection

DAVID LONARD to Bufanolides

Back to Details
This is a "connection" page, showing publications DAVID LONARD has written about Bufanolides.
DAVID LONARD
Connection Strength
0.688
Bufanolides
  1. Bufalin is a steroid receptor coactivator inhibitor-response. Cancer Res. 2015 Mar 15; 75(6):1157.
    View in: PubMed
    Score: 0.461
  2. Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug. PLoS One. 2015; 10(10):e0140011.
    View in: PubMed
    Score: 0.120
  3. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res. 2014 Mar 01; 74(5):1506-1517.
    View in: PubMed
    Score: 0.106
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.